Detalles de la búsqueda
1.
Survival outcomes of patients with oligometastatic non-small cell lung cancer who were treated with radical therapy: a multicenter analysis.
Turk J Med Sci
; 53(4): 949-961, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-38031948
2.
Efficacy and safety profile of COVID-19 vaccine in cancer patients: a prospective, multicenter cohort study.
Future Oncol
; 18(10): 1235-1244, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35081732
3.
Prognostic significance of HER2 loss after HER2-targeted neoadjuvant treatment in patients with HER2-positive locally advanced breast cancer.
Curr Probl Cancer
; 50: 101102, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38735211
4.
The Prognostic Role of Mismatch Repair Status and CDX-2 Expression with Inflammatory Markers and Pathological Risk Factors in Stage II and III Colon Cancer: Multicenter Real-Life Data.
J Gastrointest Cancer
; 2023 Jun 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37347353
5.
Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as prognostic markers in patients with extensive-stage small cell lung cancer treated with atezolizumab in combination with chemotherapy.
Medicine (Baltimore)
; 102(15): e33432, 2023 Apr 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37058061
6.
Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study.
J Cancer Res Clin Oncol
; 149(11): 8243-8253, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37067546
7.
Cetuximab-induced rash is associated with overall survival in patients with recurrent/metastatic squamous cell carcinoma of head and neck.
Cancer Chemother Pharmacol
; 88(5): 805-812, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34312705
Resultados
1 -
7
de 7
1
Próxima >
>>